Intensified Cytarabine Dose during Consolidation Therapy in AML Patients Under 65 Years Is Not Associated with Survival Benefit

▪ Background: Acute myeloid leukemia (AML) is characterized by a high relapse rate, indicating insufficient clearance of leukemia-initiating cells. Depending on genetic risk stratification, consolidating chemotherapy proves to significantly reduce the risk of relapse. In particular, in younger AML p...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Blood 2021-11, Vol.138 (Supplement 1), p.1242-1242
Hauptverfasser:	Hanoun, Maher, Ruhnke, Leo, Kramer, Michael, Schäfer-Eckhard, Kerstin, Steffen, Björn, Sauer, Tim, Krause, Stefan W., Schliemann, Christoph, Kaufmann, Martin, Haenel, Mathias, Jost, Edgar, Brummendorf, Tim H, Fransecky, Lars, Kraus, Sabrina, Einsele, Hermann, Niemann, Dirk, Neubauer, Andreas, Kullmer, Johannes, Seggewiss-Bernhard, Ruth, Goerner, Martin, Held, Gerhard, Kaiser, Ulrich, Scholl, Sebastian, Reinhardt, Hans Christian, Platzbecker, Uwe, Baldus, Claudia D., Mueller-Tidow, Carsten, Bornhaeuser, Martin, Serve, Hubert, Rollig, Christoph
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!